Logo

American Heart Association

  59
  0


Final ID: Tu053

Activin Signaling Inhibition Enhances Cardiac Functional Recovery After Aortic Debanding

Abstract Body: Background: Human aortic stenosis (AS) induces adverse cardiac remodeling and heart failure by pressure overload. Reducing pressure overload (e.g., Trans-catheter aortic valve replacement (TAVR) mitigates or reverses adverse remodeling but these benefits are limited in many TAVR patients. Here we established a murine transverse-aortic-constriction (TAC)-debanding model to mimic TAVR and identify ways to enhance reverse remodeling.
Methods: 10-week-old wild-type C57BL/6 mice were subjected to TAC surgery and debanding by suture removal, or sham-debanding, between 4 (short duration) and 10 weeks (long duration) after TAC. Echocardiography was performed to assess cardiac function. RNA sequencing (RNAseq) of TAC and debanded hearts demonstrated activation of activin signaling with TAC that was relieved by debanding. Based on this, TAC-debanded animals were treated with an investigational modified activin receptor type IIB ligand trap, RKER-012 (10 mg/kg IP, bi-weekly), to inhibit signaling downstream of activin and related ligands.
Results: Serial echocardiography of TAC-debanded animals showed greater dysfunction with longer duration TAC (Fractional shortening [FS]=39.2±3.84 for 4 weeks-TAC vs Sham: 61.2±0.94, p<0.05; FS=18.2±1.80 for 10 weeks-TAC vs Sham-TAC: 64.7±0.43, p<0.05). Cardiac functional recovery was slower and less complete in animals with longer duration TAC (10 weeks after debanding with TAC for 4 weeks, FS=57.8±1.41 vs 46.6±3.4 TAC for 10 weeks). RNAseq analysis of hearts post-debanding (10 weeks TAC+10 weeks debanding) showed a 5.73-fold decrease (p=2.57x10-16) in FSTL3 expression, a biomarker of activin pathway signaling, suggesting a decrease in activin signaling accompanied functional recovery. To assess functional contribution of activin signaling to incomplete recovery and therapeutic potential of pathway inhibitors, we treated debanded animals (debanded 8 weeks post-TAC) with RKER-012 or placebo (TBS) for 4 weeks. RKER-012-treated mice showed significantly increased ejection fraction (54.12±1.50 vs placebo control 42.88±3.21; p=0.001) and reduced heart weight (p=0.01).
Conclusions: Debanding after TAC mitigates adverse remodeling that is slower and less complete with longer duration TAC. A ligand trap (RKER-012) that was designed to inhibit signaling downstream of activin enhanced recovery after debanding and warrants further study as a potential therapeutic intervention in patients with incomplete functional recovery after TAVR.
  • Singh, Anand  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Guseh, James Sawalla  ( Mass General Brigham , Boston , Massachusetts , United States )
  • Xiao, Chunyang  ( Mass General Brigham , Boston , Massachusetts , United States )
  • Babbs, Keith  ( Keros Therapeutics Inc. , Lexington , Massachusetts , United States )
  • Seehra, Jasbir  ( Keros Therapeutics Inc. , Lexington , Massachusetts , United States )
  • Li, Haobo  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Rosenzweig, Anthony  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Author Disclosures:
    Anand Singh: DO NOT have relevant financial relationships | James Sawalla Guseh: No Answer | Chunyang Xiao: No Answer | Keith Babbs: No Answer | Jasbir Seehra: DO have relevant financial relationships ; Employee:Keros Therapeutics, Inc:Active (exists now) ; Ownership Interest:Keros Therapeutics, Inc:Active (exists now) | Haobo LI: DO NOT have relevant financial relationships | Anthony Rosenzweig: No Answer
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

Poster Session and Reception 2

Tuesday, 07/23/2024 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
A Meta-Analysis of Prospective Studies Comparing Short and Longterm Outcomes of Trans-Catheter Aortic Valve Replacement in Patient with and without Cancer:

Khan Muhammad Aslam, Haider Adnan, Haider Taimoor, Bhattarai Shraddha, Khan Bilal, Lamichhane Bikal, Shafique Nouman, Rahman Hammad, Aafreen Asna, Muhammad Anza, Bhatia Hitesh, Khan Abid Nawaz Khan, Akbar Usman, Khan Alamzaib

Acoustic Analysis For The Detection Of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

Lupu Lior, Shetrit Aviel, Kadosh Adi, Aviram Galit, Topilsky Yan, Banai Shmuel, Havakuk Ofer

More abstracts from these authors:
Cardiomyocyte-specific PLCe1 knock-down attenuates Angiotensin II-induced cardiac hypertrophy.

Ni Kareemah, Rigaud Vagner, Vigneault Patrick, Xiao Chunyang, Klattenhoff Carla, Ellinor Patrick

RKER-012, A Novel Modified ActRIIB Ligand Trap, Reversed Experimental Pulmonary Arterial Hypertension

Jain Pritesh, Seehra Jasbir, Lerner Lorena, Joshi Sachindra Raj, Babbs Keith, Nurse Tandy, Thakre Apoorv Vinod, Pinkus Cynthia, Thirumurthy Gomathi, Ishimwe Jeanne A, Fisher Ffolliott, Lachey Jennifer

You have to be authorized to contact abstract author. Please, Login
Not Available